Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma
Launched by MAYO CLINIC · Nov 23, 2015
Trial Information
Current as of May 12, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial, called "SMART," is studying how radiation therapy can help shrink tumors and prevent the spread of malignant pleural mesothelioma, a type of cancer that affects the lining of the lungs. The trial is looking for adults over 18 years old who are scheduled to receive radiation therapy followed by surgery to remove the affected tissue. Participants will need to give their consent to join the study and must be capable of making their own medical decisions. Women who could become pregnant will need to have a negative pregnancy test as part of the process.
If you join the trial, you can expect to receive standard radiation treatment followed by surgery. Researchers will collect information from your medical records and check your health regularly over time. This will help them understand how well the radiation therapy is working and how it affects the surgery outcomes. The trial is currently recruiting participants, and it's important to know that anyone under 18 years old is not eligible to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subject provides informed consent
- • Subject is \>18 years of age
- • Subject is deemed competent for making medical decisions
- • Subject is scheduled to undergo radiation followed by extrapleural pneumonectomy.
- • Subject is a surgical candidate
- • A negative pregnancy test is required in women of child-bearing potential, as standard of care.
- Exclusion Criteria:
- • Subject is \<18 years old.
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Dennis Wigle, MD, PhD
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials